Modulation of T cell cytokine production by interferon regulatory factor-4

被引:89
作者
Hu, CM [1 ]
Jang, SY [1 ]
Fanzo, JC [1 ]
Pernis, AB [1 ]
机构
[1] Columbia Univ, Dept Med, New York, NY 10032 USA
关键词
D O I
10.1074/jbc.M205895200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Production of cytokines is one of the major mechanisms employed by CD4(+) T cells to coordinate immune responses. Although the molecular mechanisms controlling T cell cytokine production have been extensively studied, the factors that endow T cells with their ability to produce unique sets of cytokines have not been fully characterized. Interferon regulatory factor (IRF)-4 is a lymphoid-restricted member of the interferon regulatory factor family of transcriptional regulators, whose deficiency leads to a profound impairment in the ability of mature CD4(+) T cells to produce cytokines. In these studies, we have investigated the mechanisms employed by IRF-4 to control cytokine synthesis. We demonstrate that stable expression of IRF-4 in Jurkat T cells not only leads to a strong enhancement in the synthesis of interleukin (IL)-2, but also enables these cells to start producing considerable amounts of IL-4, IL-10, and IL-13. Transient transfection assays indicate that IRF-4 can transactivate luciferase reporter constructs driven by either the human IL-2 or the human IL-4 promoter. A detailed analysis of the effects of IRF-4 on the IL-4 promoter reveals that IRF-4 binds to a site adjacent to a functionally important NFAT binding element and that IRF-4 cooperates with NFATcl. These studies thus support the notion that IRF-4 represents one of the lymphoid-specific components that control the ability of T lymphocytes to produce a distinctive array of cytokines.
引用
收藏
页码:49238 / 49246
页数:9
相关论文
共 60 条
  • [1] Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo
    Agarwal, S
    Avni, O
    Rao, A
    [J]. IMMUNITY, 2000, 12 (06) : 643 - 652
  • [2] T cell differentiation: a mechanistic view
    Avni, O
    Rao, A
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (06) : 654 - 659
  • [3] Assembly requirements of PU.1-Pip (IRF-4) activator complexes:: inhibiting function in vivo using fused dimers
    Brass, AL
    Zhu, AQ
    Singh, H
    [J]. EMBO JOURNAL, 1999, 18 (04) : 977 - 991
  • [4] Pip, a lymphoid-restricted IRF, contains regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1
    Brass, AL
    Kehrli, E
    Eisenbeis, CF
    Storb, U
    Singh, H
    [J]. GENES & DEVELOPMENT, 1996, 10 (18) : 2335 - 2347
  • [5] Bunn PA, 1996, J CELL BIOCHEM, P12
  • [6] T helper cell activation and human retroviral pathogenesis
    Copeland, KFT
    Heeney, JL
    [J]. MICROBIOLOGICAL REVIEWS, 1996, 60 (04) : 722 - +
  • [7] Generic signals and specific outcomes:: Signaling through Ca2+, calcineurin, and NF-AT
    Crabtree, GR
    [J]. CELL, 1999, 96 (05) : 611 - 614
  • [8] Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
    de la Pompa, JL
    Timmerman, LA
    Takimoto, H
    Yoshida, H
    Elia, AJ
    Samper, E
    Potter, J
    Wakeham, A
    Marengere, L
    Langille, BL
    Crabtree, GR
    Mak, TW
    [J]. NATURE, 1998, 392 (6672) : 182 - 186
  • [9] A 275-BASEPAIR FRAGMENT AT THE 5' END OF THE INTERLEUKIN-2 GENE ENHANCES EXPRESSION FROM A HETEROLOGOUS PROMOTER IN RESPONSE TO SIGNALS FROM THE T-CELL ANTIGEN RECEPTOR
    DURAND, DB
    BUSH, MR
    MORGAN, JG
    WEISS, A
    CRABTREE, GR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02) : 395 - 407
  • [10] PIP, A NOVEL IRF FAMILY MEMBER, IS A LYMPHOID-SPECIFIC, PU.1-DEPENDENT TRANSCRIPTIONAL ACTIVATOR
    EISENBEIS, CF
    SINGH, H
    STORB, U
    [J]. GENES & DEVELOPMENT, 1995, 9 (11) : 1377 - 1387